Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Blueprint Medicines Corp (BPMC)

$67.19 2.63 (3.77%)

19:30 EST BPMC Stock Quote Delayed 15 Minutes

Volume:

Previous Close $67.19

Market Cap 2.95B

PE Ratio -15.38

EPS -4.37

Volume (Avg. Vol.) 3.59M

Day's Range 65.10 - 68.40

52-Week Range 65.10 - 102.98

Dividend & Yield N/A (N/A)

BPMC Stock Predictions, Articles, and Blueprint Medicines Corp News

From InvestorPlace
From the Web

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Dec 18, 2019

The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

Avis Budget Group Inc. (CAR) Leads 8 Notable Investor Filings

By Fintel May 4, 2017

13G and 13D filings are windows into recent activist investor activity. We look at Avis Budget Group Inc. (CAR) and 7 others

Best & Worst Performing Mid Cap Stocks for January 23, 2020

From StockNews.com Jan 23, 2020

SRRA – SRRA leads the way today as the best performing mid cap stock, closing up 3,685.71%.

146 Biotechnology Stocks Moving In Thursday's Session

From Benzinga Jan 23, 2020

Gainers • Sierra Oncology, Inc. (NASDAQ:SRRA) stock increased by 3638.9% to $13.00 during Thursday's regular session. The most recent rating by Oppenheimer, on...

Interesting BPMC Put And Call Options For May 15th

From Market News Video Jan 23, 2020

Investors in Blueprint Medicines Corp (BPMC) saw new options become available today, for the May 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 113 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

70 Biggest Movers From Yesterday

From Benzinga Jan 23, 2020

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 64.4% to close at $1.89 on Wednesday after climbing 219.44% on Tuesday. Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) gained 33...

Blueprint Medicines prices equity offering at $69

From Seeking Alpha Jan 23, 2020

Blueprint Medicines (NASDAQ:BPMC) has priced its public offering of 4,710,144 common shares at $69 per share.Underwriters' over-allotment is an additional 706,521 shares.Closing date is January 27.

Best & Worst Performing Mid Cap Stocks for January 22, 2020

From StockNews.com Jan 22, 2020

LX – LX leads the way today as the best performing mid cap stock, closing up 13.75%.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold